《大行報告》大摩首予中國中免(01880.HK)H股「增持」評級 目標價215元
摩根士丹利發表研究報告指,由於中國中免(01880.HK)的需求及利潤復甦,預期第四季將錄得正面盈利增長,店舖的擴張和營運效率提升支持其健康的中長期增長前景。該行首予集團H股「增持」評級,目標價215元。
該行表示,中免目前的估值反映其復甦疲弱且時間上的不確定,又認為海南及集團的競爭力自2020年中以來有所增強,並有可持續的錢包份額(wallet share)。該行認為,集團AH股的估值均具有吸引力,而A股估值的上升空間略高於H股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.